LOS ANGELES --(Business Wire)--
BG Medical Technologies (OTC:RIGH) CEO, Angel Stanz has been invited to
discuss how digital media is changing the way patients and entrepreneurs
communicate about cannabis at "The State of Marijuana" event to be held
on July 26th in Hollywood, California from 1pm to 9pm. This
exclusive conversation with industry insiders is a unique opportunity
for shareholders, emerging entrepreneurs and the public to discuss key
topics with influential marijuana companies.
Medical marijuana is currently legal in 23 states, two of which have
legalized cannabis for recreational use. With the imminent reform on
marijuana laws nationwide, many societal and economic issues are being
brought to the forefront. Mr. Stanz will join key figures and opinion
leaders across business, media, and academic sectors to discuss the
implications of the nation's evolving perspectives on cannabis and what
the future will hold for this controversial herb.
Mr. Stanz will participate on the Digital Media Panel discussing BG
Medical development projects involving Bitcoin, and the potential impact
of future payment systems on the industry. Panel discussions will also
include strategies for companies looking to create online cannabis
brands, digital marketing tools currently available for cannabis
companies, and how new cannabis entrepreneurs can position themselves
within the evolving perception of cannabis in the mainstream media.
BudGenius is offering a limied time 20% discount to this special event
for all BG Medical Technologies shareholders and BudGenius.com visitors.
Eligible members are encouraged to visit www.BudGenius.com
to receive this discount and learn additional event information.
About BG Medical Technologies
BG Medical Technologies is a medical marijuana company that develops
technology and research software for cannabis and natural health
solutions. The Company collects data through a network of proprietary
software, utilized by patients, by retail operators, and by medical
professionals. The Company's current flagship product, BudGenius.com, is
a social web platform connecting cannabis patients to regionally
available medicine that is paired to their needs. The Company operates
an analytical chemistry laboratory designed for cannabis study, utilized
to determine potency and safety guidance for patients and medicine
manufacturers.
For more information please visit:
http://ift.tt/1o7kpla
http://ift.tt/1o7kq8H
The foregoing press announcement contains forward-looking statements
that can be identified by such terminology such as "believes,"
"expects," "potential," "plans," "suggests," "may," "should," "could,"
"intends," or similar expressions. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors that
may cause the actual results to be materially different from any future
results, performance or achievements expressed or implied by such
statements. In particular, management's expectations could be affected
by, among other things, uncertainties relating to our success in
completing acquisitions, financing our operations, entering into
strategic partnerships, engaging management and other matters disclosed
by us in our public filings from time to time. Forward-looking
statements speak only as to the date they are made. The Company does not
undertake to update forward-looking statements to reflect circumstances
or events that occur after the date the forward-looking statements are
made.
[ Back To TMCnet.com's Homepage ]
| 
